"We are in the last phase of evaluation on what price we need to charge for oral incretin in India. By September we will have complete picture," said Vikrant Shrotriya, Corporate Vice-President and Managing Director of Novo Nordisk India in an interview to Moneycontrol.Novo Nordisk to launch two medications for diabetes, weight loss in 2022
"We are in the last phase of evaluation on what price we need to charge for oral incretin in India. By September we will have complete picture," said Vikrant Shrotriya, Corporate Vice-President and Managing Director of Novo Nordisk India in an interview to Moneycontrol.
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
No comments:
Post a Comment